Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Form 8.3 - [Forward Partners Group plc - Opening Disclosure - 27 11 2023] - (CGAML)
-
Form 8.3 - [Molten Ventures plc - Opening Disclosure - 27 11 2023] - (CGAML)
-
Form 8.3 - [Picton Property Income Limited - 27 11 2023] - (CGWL)
-
Canaccord Genuity Upgrades NG Energy International Corp (GASX:CN) to Buy
-
Canaccord Genuity Starts Meteoric Resources NL (MEI:AU) at Spec. Buy
-
Hastings Technology Metals Ltd (HAS:AU) PT Lowered to AUD2.50 at Canaccord Genuity
-
Form 8.3 - [Young & Co.'s Brewery 24 11 2023] - (CGWL)
-
Andean Precious Metals Acquires Producing Heap Leach Gold Mine; Expands Its Footprint into the U.S.
-
Corporate Update
-
Bionxt Solutions Announces Convertible Debenture and Interest Settlement
-
Form 8.3 - [Young & Co.'s Brewery 23 11 2023] - (CGWL)
-
Form 8.3 - Young & Co.'s Brewery - 22 11 2023 - (CGWL)
-
Form 8.3 - Picton Property Income Limited - 22 11 2023 - (CGWL)
-
Docebo (DCBO) Announces CEO Succession
-
Docebo Inc. Announces CEO Succession and Substantial Issuer Bid
-
Form 8.3 - Young & Co.'s Brewery - 20 11 2023 - (CGWL)
-
Form 8.3 - musicMagpie plc - 20 11 2023 - Opening Disclosure (CGAML)
-
Form 8.3 - Velocys plc - 20 11 2023 - Opening Disclosure (CGAML)
-
Form 8.3 - Picton Property Income Limited - 20 11 2023 - (CGWL)
-
Interim Management Statement
-
Statement re Company Event
-
Primaris REIT Announces Successful $400 Million Unsecured Debenture Offering
-
Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rare Disease Company
-
Flow Capital Announces Normal Course Issuer Bid For Common Shares
-
ValOre Initiates Comprehensive Metallurgical Testwork Program at Pedra Branca
-
Form 8.3 - [Young & Co.'s Brewery 17 11 2023] - (CGWL)
-
Form 8.3 - City Pub Group plc - 16 11 2023 - Opening Disclosure (CGAML) (correction for part 1a)
-
UGE Closes Offering of Project Development Green Bonds
-
Form 8.3 - Young & Co.'s Brewery - 16 11 2023 - (CGWL)
-
Form 8.3 - Young & Co.'s Brewery - 16 11 2023 - Opening Disclosure (CGAML)
-
Form 8.3 - City Pub Group plc - 16 11 2023 - Opening Disclosure (CGWL)
-
Form 8.3 - City Pub Group plc - 16 11 2023 - Opening Disclosure (CGAML)
-
Thor Explorations Announces Notice of Annual General Meeting
-
Arrow Provides RCE-6 Update and Operations Update
-
Trail Blazing Ventures Ltd. Enters into Definitive Agreement with Hempalta Inc. in Respect of Proposed Qualifying Transaction
-
Cytrellis to Present at Canaccord Genuity CG MedTech Diagnostics and Digital Health & Services Forum
-
CANACCORD GENUITY GROUP INC. REPORTS SECOND QUARTER FISCAL 2024 RESULTS
-
Ero Copper (ERO) Completes $111M Bought Deal Financing
-
Ero Copper Completes US$111 Million Bought Deal Financing
-
Bragg Gaming Group Inc (BRAG:CN) PT Lowered to Cdn$13 at Canaccord Genuity
-
The Cannabist Company Announces Normal Course Issuer Bid
-
Form 8.3 - DX (GROUP) PLC - 13 11 2023 - (CGAML)
-
Canaccord Genuity Downgrades Vicarious Surgical inc. (RBOT) to Hold, 'Struggles continue'
-
Canaccord Downgrades The Beauty Health Company (SKIN) to Hold, 'lack of visibility of SKIN returning to growth plan'
-
Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
Accure Acne, Inc to Present at Canaccord Genuity Medtech, Diagnostics, and Digital Health & Services
-
QuoteMedia Announces 8% (10% FXN) Revenue Growth for Q3 2023
-
Calibre and Marathon Announce Combination to Create a High-Growth, Cash Flow Focused, Mid-Tier Gold Producer in the Americas with Expected Annual Production of 500,000 ounces
-
UGE Announces Update to Size of Offering of Project Development Green Bonds and Filing of Final Short Form Prospectus
-
Progyny, Inc. to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

